Last reviewed · How we verify

Mannitol cream

University of British Columbia · Phase 3 active Small molecule

Mannitol cream acts as a topical osmotic agent that draws fluid from underlying tissues to reduce edema and inflammation in skin conditions.

Mannitol cream acts as a topical osmotic agent that draws fluid from underlying tissues to reduce edema and inflammation in skin conditions. Used for Dermatological condition under investigation (specific indication not publicly confirmed).

At a glance

Generic nameMannitol cream
Also known asMannitol, PENcream, Commercially available proprietary cream., Mannitol in vehicle cream, QR cream
SponsorUniversity of British Columbia
Drug classTopical osmotic agent
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

Mannitol is a sugar alcohol that creates an osmotic gradient when applied topically, pulling interstitial fluid toward the skin surface and reducing local swelling. This mechanism may help reduce inflammation, improve wound healing, and provide symptomatic relief in dermatological conditions. The exact therapeutic target in this Phase 3 formulation requires clarification from clinical trial data.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results